Despite attempts by our great Governor Goodhair, Texas’s colleges keep spewing out amazing research. Recently, we learned some of that research involves cannabinoid receptors drugs. We know where they come from, and that they help with Alzheimers and cancer treatment … but we’re just at the beginning of our understanding of how they work.
I’m frequently excited by the crazy stuff being done at Texas A&M, but it doesn’t usually have anything to do with this blog. Thanks to Dr. Dai Lu, a former Harvard instructor, Texas A&M’s pharmaceutical department has a chance to take the study of cannabinoid receptors seriously.
The face of seriousness.
Lu studies nanomedicine, and cannabinoid receptor research is just a fraction of what he does.
So here’s the deal: We have a receptor in our cells that gets activated by THC. Cancer cells, according to Dr. Lu, have more of those receptors than healthy cells. So if you could create a nanodrug that selectively activates the extra cannabinoid receptors, you could kill a cancer cell without killing the regular cells.
It’s not like they’ll have bricks of pot lying around A&M’s campus. They don’t need to use cannabis or even THC as the trigger mechanism. But it’s thanks to cannabis research that this kind of stuff is possible.
Y’all still have to get your bricks at Texas State.
By the way, we found out about this one through Texas Cannabis Report, a great source for all things Texas, Cannabis and report-related.